Harding Jane L, Sywak Mark S, Sidhu Stan, Delbridge Leigh W
University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, Sydney, New South Wales, Australia.
ANZ J Surg. 2004 Jun;74(6):442-5. doi: 10.1111/j.1445-1433.2004.03030.x.
Injury to the cervical sympathetic chain and its consequence, Horner's syndrome, as a result of thyroid pathology or surgical intervention is an uncommon complication. The purpose of the present study was to examine the experience of one endocrine surgical unit with pre and postoperative Horner's syndrome.
This is a retrospective case series. The study group comprised all patients undergoing thyroid and parathyroid surgery at Royal North Shore Hospital from January 2000 to October 2003 who were identified as having either pre or postoperative Horner's syndrome. Patient demographics, operation performed, underlying pathology and outcomes were evaluated.
There were nine cases of Horner's syndrome recorded from a total of 2208 thyroid and parathyroid operations undertaken: three with preoperative Horner's, an incidence of 0.14%, six with postoperative Horner's, an incidence of 0.27%. Patients ranged in age from 22 to 87 years. Two of the three preoperative cases were related to benign pathology, the remaining case having anaplastic carcinoma. Five of the six postoperative cases were related to thyroid malignancy with lymph node dissection; one case was associated with benign parathyroid pathology.
Cervical sympathetic chain injury is a rare complication of surgery for thyroid and parathyroid conditions. The presence of preoperative Horner's does not necessarily indicate an underlying malignancy.
因甲状腺疾病或手术干预导致颈交感神经链损伤及其后果——霍纳综合征,是一种罕见的并发症。本研究的目的是探讨某一内分泌外科单元处理术前及术后霍纳综合征的经验。
这是一项回顾性病例系列研究。研究组包括2000年1月至2003年10月在皇家北岸医院接受甲状腺和甲状旁腺手术且被确定患有术前或术后霍纳综合征的所有患者。对患者的人口统计学资料、所进行的手术、基础病理情况及结局进行了评估。
在总共2208例甲状腺和甲状旁腺手术中,记录到9例霍纳综合征:3例术前霍纳综合征,发生率为0.14%;6例术后霍纳综合征,发生率为0.27%。患者年龄在22岁至87岁之间。3例术前病例中有2例与良性病变有关,其余1例为间变性癌。6例术后病例中有5例与甲状腺恶性肿瘤伴淋巴结清扫有关;1例与良性甲状旁腺病变有关。
颈交感神经链损伤是甲状腺和甲状旁腺疾病手术的罕见并发症。术前存在霍纳综合征不一定表明存在潜在恶性肿瘤。